Factors Associated with Prescribing Errors at the Premium Outpatient Pharmacy in Somdech Phra Debaratana Medical Center
Main Article Content
Abstract
Objective: To investigate the factors associated with prescription errors (PEs) in the outpatient pharmacy at Somdech Phra Debaratana Medical Center. Methods: This retrospective analytical research collected the data from 82,137 prescriptions during January 1, 2024 to March 1, 2024. Seven predictive factors in the study were prescribing system, estimated glomerular filtration rate (eGFR), prescription with warfarin, hospital unit providing care to patients, number of drug items in prescription, patients receiving more than one prescription in one day, and medications with quantity restrictions based on hospital policy. The association between PEs and these factors was analyzed using logistic regression. Results: Factors significantly influencing PEs included patients with eGFR ≥ 30 and < 60 mL/min/1.73m² (ORadjust =1.31, 95% CI=1.20-1.44, P<0.001), eGFR < 30 mL/min/1.73m² (ORadjust =1.99, 95% CI=1.75-2.27, P<0.001), absence of eGFR (ORadjust =0.87, 95% CI=0.79-0.97, P=0.011), prescription of medicine department (ORadjust =1.95, 95% CI=1.72-2.22, P<0.001), prescription of surgery and orthopedic department (ORadjust =2.95, 95% CI=2.58-3.39, P<0.001), prescription with 3-4 drug items (adjusted ORadjust =1.53, 95% CI=1.39-1.67, P<0.001), prescription with 5-6 drug items (ORadjust =2.18, 95% CI=1.97-2.42, P<0.001), prescription with more than 7 drug items. (ORadjust =4.13, 95% CI=3.76-4.53, P<0.001), patients receiving more than one prescription per day (ORadjust =1.37, 95% CI=1.27-1.48, P<0.001), and prescriptions with medications restricted by hospital policy (ORadjust =4.21, 95% CI=3.88-4.58, P<0.001). Factors with no association with PEs included prescribing system and prescriptions with warfarin. Three most commonly found PEs were incorrect dosage/frequency/duration, prescribing in CPOE system with medication units not consistent to drugs and prescriptions not complying with hospital policies. Top three drugs involving in PEs were denosumab, icosapent ethyl and erythropoietin alfa Conclusion: Top three factors with the highest association with PEs included prescriptions with medications restricted by hospital policy, having at least 7 drug items in prescriptions, and prescription of surgery and orthopedic department. The Hospital should consider identified significant factors in the effort to improve the prescribing system and presented them to the Pharmacy and Therapeutics Committee for establishing safer prescribing practices, and reducing PEs in order to maximize patients’ drug safety.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Ningsanon T, Ratanawijitrasin S. Hospital drug system performance indicators. 2 ed. Bangkok: Pora- matkanpim; 2008.
Samp J, Touchette D, Marinac J, Kuo G, American College of Clinical Pharmacy Practice-Based Research Network C. Economic evaluation of the impact of medication errors reported by US clinical pharmacists. Pharmacotherapy 2014; 34: 350-7.
Association of Hospital Pharmacy (Thailand). Basic framework of drug system [online]. 2020 [cited Aug 15, 2024]. Available from: backend.ha.or.th/fileup load/DOCUMENT/00514/72647587-6d96-428e-8de 6-9f9c3fd88776.pdf
National Coordinating Council for Medication Error Report and Prevention (NCC MERP). Types of medication errors [online]. 2017 [cited Jul 8, 2024]. Available from: www.nccmerp.org/ types-medication-errors.
Albarrak AI, Al Rashidi EA, Fatani RK, Al Ageel SI, Mohammed R. Assessment of legibility and completeness of handwritten and electronic prescriptions. Saudi Pharm J 2014; 22: 522-7.
Manias E, Street M, Lowe G, Low JK, Gray K, Botti M. Associations of person-related, environment-related and communication-related factors on medication errors in public and private hospitals: a retrospective clinical audit. BMC Health Serv Res 2021; 21: 1025.
Rasool MF, Rehman AU, Imran I, Abbas S, Shah S, Abbas G, et al. Risk factors associated with medication errors among patients suffering from chronic disorders. Front Public Health 2020; 8: 531038.
Phianchana C. Predictive factors for outpatient prescribing errors at Phrachomklao Phetchaburi hospital. Thai Bulletin of Pharmaceutical Sciences 2024; 19: 1-18.
Kebede B, Kefale Y. Medication error patients admitted to medical ward in primary hospital, Ethiopia: prospective observational study. J Pharma Care Health Sys 2019; 6: 205. doi:10.35248/2376-0419.19.6.205
Mahomedradja RF, Schinkel M, Sigaloff KC, Reumerman MO, Otten RH, Tichelaar J, et al. Factors influencing in‐hospital prescribing errors: A systematic review. Br J Clin Pharmacol 2023; 89: 1724-35.
Ningrum SOP, Prabasari MR, Chalidyanto D. Completeness of prescription contributes to
prescribing errors in hospitals: Is this the doctor’s negligence?. Biomol Health Sci J 2022; 5: 77-80.
Seden K, Kirkham JJ, Kennedy T, Lloyd M, James S, Mcmanus A, et al. Cross-sectional study of prescribing errors in patients admitted to nine hospitals across North West England. BMJ Open 2013; 3: e002036.
Alshahrani F, Marriott JF, Cox AR. A qualitative study of prescribing errors among multi-professional prescribers within an e-prescribing system. Int J Clin Pharm 2021; 43: 884-92.
Kruse C, Smith M, Clarke D. Technology alone does not achieve error reduction–a study of handwritten, tick-sheet, ink stamp and electronic medical prescriptions. S Afr J Surg 2022; 60: 259-67.
Kidney Disease improving global outcomes. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease [online]. 2024 [cited Aug 7, 2024]. Available from: www.kidney-international.org/action/showPdf?pii=S0 085-2538%2823% 2900766-4
Hirsch JS, Brar R, Forrer C, Sung C, Roycroft R, Seelamneni P, et al. Design, development, and deployment of an indication-and kidney function-based decision support tool to optimize treatment and reduce medication dosing errors. JAMIA Open. 2021; 4: ooab039